top
Search terms
Results 1 - 10 of 31 - ordered by :
Pages: 1 2 3 4
Ejhf

Some evidence suggests that levosimendan does not increase myocardial oxygen consumption for a given inotropic effect when compared with the pharmacodynamic properties of traditional inotropic agents ...

European Journal of Heart Failure, Omerovic, Elmir, Waagstein, Finn, Swedberg, Karl

Date : 01/04/2010 Item size : 89177 bytes
Ejhf

On Wednesday the 4 March 2009 we received the tragic news that our colleague and friend Philip Poole-Wilson died suddenly in London on his way to give a lecture to medical students. Philip ...

European Journal of Heart Failure, Cleland, John G.F., Swedberg, Karl

Date : 01/05/2009 Item size : 44842 bytes
Ejhf

Some evidence suggests that levosimendan does not increase myocardial oxygen consumption for a given inotropic effect when compared with the pharmacodynamic properties of traditional inotropic agents ...

European Journal of Heart Failure, Omerovic, Elmir, Waagstein, Finn, Swedberg, Karl

Date : 01/04/2010 Item size : 89225 bytes
Ejhf

The inconsistent use of arbitrary thresholds for enrolling patients in clinical trials for ‘systolic’ and ‘diastolic’ HF hampers discrimination of the effect on outcomes of LVEF as a ...

European Journal of Heart Failure, Toma, Mustafa, Ezekowitz, Justin A., Bakal, Jeffrey A., O'Connor, Christopher M., Hernandez, Adrian F., Sardar, Muhammad Rizwan, Zolty, Ronald, Massie, Barry M., ...

Date : 01/03/2014 Item size : 179586 bytes
Ejhf

Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document In ASCEND-HF, specific clinical variables including older age, ...

European Journal of Heart Failure, Zannad, Faiez, Garcia, Angeles Alonso, Anker, Stefan D., Armstrong, Paul W., Calvo, Gonzalo, Cleland, John G.F., Cohn, Jay N., Dickstein, Kenneth, Domanski, Michael ...

Date : 01/10/2013 Item size : 366395 bytes
Ehjournal

Guidelines on the management of valvular heart disease (version 2012)The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European ...

European Heart Journal, Vahanian, Alec, Alfieri, Ottavio, Andreotti, Felicita, Antunes, Manuel J., Barón-Esquivias, Gonzalo, Baumgartner, Helmut, Borger, Michael Andrew, Carrel, Thierry P., De ...

Date : 01/10/2012
Ehjournal

Aims The 6min walk test (6MWT) is commonly used in clinical trials to assess treatments for heart failure, but its ability to distinguish between effective and ineffective treatments is ...

European Heart Journal, Olsson, Lars G., Swedberg, Karl, Clark, Andrew L., Witte, Klaus K., Cleland, John G.F.

Date : 01/04/2005
Ehjournal

Aims The globalization of clinical trials has highlighted geographic variations in patient characteristics, event rates, and treatment effects. Notable differences included: WE patients (mean age 68 ...

European Heart Journal, Kristensen, Søren Lund, Martinez, Felipe, Jhund, Pardeep S., Arango, Juan Luis, Bĕlohlávek, Jan, Boytsov, Sergey, Cabrera, Walter, Gomez, Efrain, Hagège, Albert ...

Date : 01/11/2016 Item size : 314421 bytes
Ehjournal

Evidence-based medicine and clinical guidelines are based on the results of randomized controlled trials. [...]we investigated how patients who fulfilled the enrolment criteria of randomized trials ...

European Heart Journal, Lenzen, Mattie J., Boersma, Eric, Scholte op Reimer, Wilma J.M., Balk, Aggie H.M.M., Komajda, Michel, Swedberg, Karl, Follath, Ferenc, Jimenez-Navarro, Manuel, Simoons, ...

Date : 01/12/2005
Ehjournal

Aims The 6min walk test (6MWT) is commonly used in clinical trials to assess treatments for heart failure, but its ability to distinguish between effective and ineffective treatments is ...

European Heart Journal, Olsson, Lars G., Swedberg, Karl, Clark, Andrew L., Witte, Klaus K., Cleland, John G.F.

Date : 01/04/2005